Synchronicity Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.6M

  • Investors
  • 2

Synchronicity Pharma General Information

Description

Developer of circadian rhythm therapeutics designed to treat sleep-wake disorders and cancers by targeting core biological clock mechanisms. The company's therapeutics utilize circadian biology, core clock protein modulation, and molecular-target discovery to develop treatments for sleep-wake disorders and difficult-to-treat cancers, enabling patients and healthcare providers to address diseases associated with disrupted biological rhythms and clock-regulated pathways.

Contact Information

Website
www.synchronicitypharma.com
Formerly Known As
Sircadian, Reset Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1416 Saratoga Avenue
  • Suite 133
  • San Jose, CA 95129
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1416 Saratoga Avenue
  • Suite 133
  • San Jose, CA 95129
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synchronicity Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 25-Jan-2022 $1.6M Completed Generating Revenue
5. Later Stage VC 23-Oct-2019 Completed Generating Revenue
4. Later Stage VC (Series B) 18-Feb-2016 Completed Generating Revenue
3. Later Stage VC (Series A) 26-Nov-2013 Completed Generating Revenue
2. Grant 07-Jan-2013 $1M Completed Generating Revenue
1. Early Stage VC 01-Jan-2008 Completed Startup
To view Synchronicity Pharma’s complete valuation and funding history, request access »

Synchronicity Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Synchronicity Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Synchronicity Pharma Patents

  • 37

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Synchronicity Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023154093-A Carbazole-containing amides, carbamates and urea as cryptochrome modulators Pending 07-Apr-2014
JP-2019142959-A Carbazole-containing amides, carbamates and ureas as cryptochrome modulators Inactive 07-Apr-2014
JP-2021155449-A Carbazole-containing amides, carbamates and ureas as cryptochrome modulators Inactive 07-Apr-2014
AU-2015244060-A1 Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators Active 07-Apr-2014
AU-2015244060-B2 Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators Inactive 07-Apr-2014 C07D401/06
To view Synchronicity Pharma’s complete patent history, request access »

Synchronicity Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synchronicity Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alkermes Corporation Minority
Bay City Capital Venture Capital Minority
To view Synchronicity Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Synchronicity Pharma FAQs

  • When was Synchronicity Pharma founded?

    Synchronicity Pharma was founded in 2008.

  • Where is Synchronicity Pharma headquartered?

    Synchronicity Pharma is headquartered in San Jose, CA.

  • What is the size of Synchronicity Pharma?

    Synchronicity Pharma has 4 total employees.

  • What industry is Synchronicity Pharma in?

    Synchronicity Pharma’s primary industry is Drug Discovery.

  • Is Synchronicity Pharma a private or public company?

    Synchronicity Pharma is a Private company.

  • What is Synchronicity Pharma’s current revenue?

    The current revenue for Synchronicity Pharma is .

  • How much funding has Synchronicity Pharma raised over time?

    Synchronicity Pharma has raised $53.6M.

  • Who are Synchronicity Pharma’s investors?

    Alkermes and Bay City Capital have invested in Synchronicity Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process